Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,748.71
    +404.51 (+0.80%)
     

  • CMC Crypto 200

    1,328.42
    +51.44 (+4.03%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
BRANDS:

Meet one of the UK’s largest unknown start-ups

Video editing platform Veed has grown to 10 million users

Diasorin CEO acquitted in Italy over alleged insider trading

Reuters
·1-min read

MILAN (Reuters) - An Italian court on Tuesday acquitted the chief executive of Italian diagnostics group Diasorin over allegations of insider trading.

A panel of three judges in Milan acquitted Carlo Rosa, along with Alessandro Venturi, President of Policlinico San Matteo hospital in the northern city of Pavia.

Prosecutors had themselves requested that Rosa be acquitted, while they asked for Venturi to be sentenced to two years' imprisonment.

Rosa and Venturi were sent to trial last year on charges of revealing details about Diasorin's new COVID-19 test before it was announced in April 2020.

ADVERTISEMENT

Three people who were given the details were alleged to have made a total profit of 5,500 euros ($5,955) on trading in shares of the company.

Diasorin had at the time of the allegations reiterated its full confidence in the work of its CEO and said it was confident he would be cleared of wrongdoing. ($1 = 0.9236 euros)

(Reporting by Emilio Parodi; Editing by Keith Weir)